期刊文献+

Design, Synthesis and Antitubulin Activity of Novel Podophyllotoxin Derivatives as Potent Anticancer Agent

Design, Synthesis and Antitubulin Activity of Novel Podophyllotoxin Derivatives as Potent Anticancer Agent
原文传递
导出
摘要 Twenty novel podophyllotoxin derivatives(1-20) were designed and synthesized. The anti-proliferation activities of these compounds were evaluated against three human cancer cell lines(HepG2, Calu-1 and MCF-7) using podophyllotoxin and Combretastatin A4(CA-4) as positive controls. Among all the compounds, compound 2 displayed more significant anti-proliferation activities against MCF-7 and Calu-1 cell lines and showed lower toxicity towards non-cancer cells. Furthermore, the cell cycle and apoptosis analysis results revealed that compound 2 can cause cell arrest at G2/M phase, leading to cancer cell apoptosis. Meanwhile, it can also reduce the adhesive ability of Calu-1 cells to fibronectin and laminin. The docking simulation results demonstrated that compound 10 can nicely bind to the colchicine site of tubulin. The podophyllotoxin derivatives are worthy to be further investigated to obtain more potent anti-cancer drugs. Twenty novel podophyllotoxin derivatives(1-20) were designed and synthesized. The anti-proliferation activities of these compounds were evaluated against three human cancer cell lines(HepG2, Calu-1 and MCF-7) using podophyllotoxin and Combretastatin A4(CA-4) as positive controls. Among all the compounds, compound 2 displayed more significant anti-proliferation activities against MCF-7 and Calu-1 cell lines and showed lower toxicity towards non-cancer cells. Furthermore, the cell cycle and apoptosis analysis results revealed that compound 2 can cause cell arrest at G2/M phase, leading to cancer cell apoptosis. Meanwhile, it can also reduce the adhesive ability of Calu-1 cells to fibronectin and laminin. The docking simulation results demonstrated that compound 10 can nicely bind to the colchicine site of tubulin. The podophyllotoxin derivatives are worthy to be further investigated to obtain more potent anti-cancer drugs.
出处 《Chemical Research in Chinese Universities》 SCIE CAS CSCD 2015年第6期964-969,共6页 高等学校化学研究(英文版)
基金 Supported by the National Natural Science Foundation of China(No.21376112), the Natural Science Foundation of the Col- leges and Universities in Jiangsu Province, China(No.13KJB350002) and the Natural Science Foundation of the Colleges and Universities Maj or Project in Jiangsu Province, ChinafNo. 15KJA350001).
关键词 Podophyllotoxin ANTICANCER Antitubulin Cell adhesion Podophyllotoxin Anticancer Antitubulin Cell adhesion
  • 相关文献

参考文献26

  • 1Karikas G. A., J. Buon., 2010, 15(4), 627.
  • 2Mishra B. B., Tiwari V. K., Eur. J. Med. Chem., 2011, 46, 4769.
  • 3Zhang E N., Li Z. E, Zhao C. Q., Nat. Prod. Res. Dev., 2004, 16(1), 80.
  • 4Gordaliza M., Clin. Transl. Oncol., 2007, 9(12), 767.
  • 5Shang H., Chen H., Zhao D. M., Tang X. W., Liu Y. F., Pan L., Cheng M. S., Arch. Pharm. Chem. Life Sci., 2012, 345(1), 43.
  • 6Bohlin L., Rosen B., Drug Discov. Today, 1996, 1(8), 343.
  • 7Kumar A., Kumar V., Alegria A. E., Malhotra S. V., Curr. Med. Chem., 2011, 18(25), 3853.
  • 8Sang C. Y., Liu J. E, Qin W. W., Zhao L, Hui L., Jin Y. X., Chen S. W., Eur .Z Med. Chem., 2013, 70, 59.
  • 9You Y, Cur~ Pharm. Des., 2005, 11(13), 1695.
  • 10Liu Y. Q., Yang L., Tian X., Curr Bioact. Compd., 2007, 3(1), 37.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部